Fennec Pharmaceuticals (FRX.TO) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.19
-0.13
-0.08
-0.03

Details

Expected EPS
-0.030973758000960003
Actual EPS
-0.02827219494544
Surprise EPS
0
Surprise Percent
+8.72%

Description

Fennec Pharmaceuticals (FRX.TO) has reported earnings of -0.02827219494544 per share for Q4 2025.

0 Comments

Share your thoughts